DS
AMPE

David Shaw’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

David Shaw’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-405
Closed -$20K – 5751
2022
Q2 		$20K Buy
405
+235
+138% +$17.5K ﹤0.01% 5023
2022
Q1 		$24K Sell
170
-3,713
-96% -$542K ﹤0.01% 5307
2021
Q4 		$664K Buy
3,883
+2,488
+178% +$928K ﹤0.01% 4229
2021
Q3 		$695K Buy
1,395
+1,223
+711% +$567K ﹤0.01% 3872
2021
Q2 		$86K Buy
+172
New +$92.4K ﹤0.01% 4574
2016
Q2 		– Sell
-195
Closed -$132K – 3600
2016
Q1 		$132K Buy
195
+5
+3% +$3.37K ﹤0.01% 3250
2015
Q4 		$199K Sell
190
-12
-6% -$11.9K ﹤0.01% 3562
2015
Q3 		$175K Sell
202
-203
-50% -$170K ﹤0.01% 3528
2015
Q2 		$288K Buy
405
+82
+25% +$87.4K ﹤0.01% 3435
2015
Q1 		$730K Buy
323
+25
+8% +$42.6K ﹤0.01% 2794
2014
Q4 		$306K Buy
298
+198
+198% +$212K ﹤0.01% 3633
2014
Q3 		$106K Buy
100
+18
+22% +$30.3K ﹤0.01% 3977
2014
Q2 		$206K Sell
82
-383
-82% -$782K ﹤0.01% 3975
2014
Q1 		$885K Buy
+465
New +$1.1M ﹤0.01% 3142
2013
Q4 		– Sell
-48
Closed -$107K – 4766
2013
Q3 		$107K Buy
+48
New +$92.8K ﹤0.01% 4182

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
SA
Shilanski & Associates Anchorage, Alaska $376M AUM 19.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

David Shaw's AMPE Position: Q3 2022 in Review

David Shaw sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2022, closing a stake of 405 shares — an estimated $20K sold.

David Shaw first reported a position in AMPE in Q3 2013 and held it in 15 quarters. The position peaked at $885K in Q1 2014. 95 funds tracked by Wall St. Rank hold AMPE as of Q3 2022.

  • David Shaw reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2022 after selling out during the quarter.
  • David Shaw sold 405 Ampio Pharmaceuticals Inc. shares in Q3 2022, an estimated $20K.
  • David Shaw first reported a position in Ampio Pharmaceuticals Inc. in Q3 2013 and held it in 15 quarters.
  • David Shaw's Ampio Pharmaceuticals Inc. position peaked at $885K in Q1 2014.
  • 95 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.